|
|
For injectable drugs, the most common primary packaging containers have been glass syringes and vials; however, glass packaging presents several challenges. Drug manufacturers seeking alternative methods for safe and reliable drug delivery should consider blow/fill/seal technology, as it offers benefits over traditional glass packaging.
|
|
|
|
Drug companies must review their manufacturing processes consistently to make them more efficient and to stay competitive. Maximized uptime, minimized changeover time, and efficient overall equipment effectiveness (OEE) are key factors that have influenced the acceptance of aseptic blow/fill/seal in the packaging of pharmaceutical liquids.
|
|
|
|
Determining the right packaging choice for any pharmaceutical can be challenging. Despite the benefits of blow/fill/seal (B/F/S) over glass, some pharmaceutical companies refuse to make the switch due to several objections. Explore how an investment in B/F/S may yield incredible long-term savings.
|
|
|
|
Multicomponent filling and sterilizing systems represent unique advantages for vaccine production. With appropriate changes to process parameters, B/F/S systems can be adapted for vaccine production without incurring any product degradation, and their widespread implementation can be achieved through adaptive strategies.
|
|
|
|
The aseptic B/F/S process has proven to be an ideal system for the creation of a wide variety of container shapes and sizes used for packaging sterile pharmaceutical liquids. Learn in detail about insertion applications in advanced aseptic B/F/S, advanced insertion isolation technology, and how B/F/S technology is expanding.
|
|
|
|
Large Volume Parenteral Bottle Deflasher
|
Here, we demonstrate our LVP bottle deflashing machine processing 500ml LVP bottles from our 14-cavity mold and B/F/S machine. See the process, from how the resin pellets are extruded to form the sterile container, to filling, to sealing, in just a matter of seconds.
|
• Request Information
|
|
|
|
|
|
|
|
|
|